SEC 13F Intelligence

Ronit Capital LLP / NVCT

Ronit Capital LLP’s Nuvectis Pharma Inc Position

Does Ronit Capital LLP own Nuvectis Pharma Inc (NVCT)? Yes562.5K shares worth $4M (+5.37% of its 13F portfolio) as of Q3 2022, up from 419.3K shares the prior filed quarter.

Position Value
$4M
Q3 2022
Shares
562.5K
% of Portfolio
+5.37%
Quarters Held
3
currently held

Position History NVCT

Reported value by quarter
Q1 ’22: $4MQ1 ’22Q2 ’22: $5MQ2 ’22Q3 ’22: $4MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2022562.5K$4M+5.37%
Q2 2022419.3K$5M+6.66%
Q1 2022550.0K$4M+5.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ronit Capital LLP’s full portfolio or all institutional holders of NVCT.